economy
April 2, 2026
NO FURTHER THAN THIS: Trump Administration Introduces 100% Tariffs on Medicines!
Last year, the US agreed to limit tariffs on medicines from the EU to 15% as part of an agreement reached with the bloc in Turnberry, Scotland.
TL;DR
- The U.S. administration is preparing to introduce 100% tariffs on certain drugs.
- These tariffs aim to encourage pharmaceutical companies to increase domestic production in the U.S.
- Companies that have not reached agreements with the White House will face the 100% tariffs.
- Agreements made with the White House will limit tariffs according to the terms of those agreements.
- Some major pharmaceutical companies have already agreed to increase U.S. investments and lower drug prices in exchange for tariff deferrals.
- The U.S. seeks to lower prescription drug prices, which are significantly higher than in other wealthy nations.
- Last year, the U.S. agreed to a 15% tariff limit on EU medicines as part of a deal.
- The UK also reached an agreement with the U.S. to reduce drug tariffs for three years in exchange for increased NHS spending on medicines.
- Pharmaceutical companies have postponed new drug launches in Europe due to pressure from the U.S. and changes in pricing policy.